PACDB provides the information on pathogens (e.g. bacteria, fungus, toxin and virus) adhering to carbohydrates expressed on the cell surface of host animals or plants.
Database | Last Updated |
---|---|
Pathogen Adherence to Carbohydrate Database (PACDB) | June 1, 2016 |
Species | Pathogen Adherence Molecule ▼ | Ligand Name | Ligand Feature | Target Source | Glycan Sequence | Binding | PubMed ID |
---|---|---|---|---|---|---|---|
B subunit
|
unnamed ligand
|
Glycosphingolipids
|
Human meconium
|
Fuc(a1-2)Gal(b1-3)GalNAc(b1-3)Gal(a1-4)Gal(b1-4)Glc(b1-1)Cer
|
Not Binding
|
||
B subunit
|
Gal-nLc4Cer; P1 antigen (GSL)
|
Oligoglycosylceramides
|
Human type B erythrocytes
|
Gal(a1-4)Gal(b1-4)GlcNAc(b1-3)Gal(b1-4)Glc(b1-1)Cer
|
Binding
|
||
B subunit
|
isoGb3 (Isoglobotriaosylceramide; iGb3)
|
Oligoglycosylceramides
|
Dog small intestine
|
Gal(a1-3)Gal(b1-4)Glc(b1-1)Cer
|
Not Binding
|
||
B subunit
|
unnamed ligand
|
Oligoglycosylceramides
|
Human kidney
|
GalNAc(a1-3)[Fuc(a1-2)]Gal(b1-3)GalNAc(b1-3)Gal(a1-4)Gal(b1-4)Glc(b1-1)Cer
|
Not Binding
|
||
B subunit
|
Asialo-GM2 (Gangliotriosylceramide; GgO3)
|
Oligoglycosylceramides
|
Mouse small intestine
|
GalNAc(b1-4)Gal(b1-4)Glc(b1-1)Cer
|
Not Binding
|
||
B subunit
|
B6 type 2 glycosphingolipid (B6-2)
|
Oligoglycosylceramides
|
Human erythrocytes
|
Gal(a1-3)[Fuc(a1-2)]Gal(b1-4)GlcNAc(b1-3)Gal(b1-4)Glc(b1-1)Cer
|
Not Binding
|
||
B subunit
|
Gb5 (Forssman glycolipid)
|
Oligoglycosylceramides
|
Dog small intestine
|
GalNAc(a1-3)GalNAc(b1-3)Gal(a1-4)Gal(b1-4)Glc(b1-1)Cer
|
Not Binding
|
||
B subunit
|
isoGb4 (Isoglobotetraosylceramide; iGb4)
|
Oligoglycosylceramides
|
Rat small intestine
|
GalNAc(b1-3)Gal(a1-3)Gal(b1-4)Glc(b1-1)Cer
|
Not Binding
|
||
B subunit
|
Alpha-Galactosyl paragloboside
|
Oligoglycosylceramides
|
Rabbit erythrocytes
|
Gal(a1-3)Gal(b1-4)GlcNAc(b1-3)Gal(b1-4)Glc(b1-1)Cer
|
Not Binding
|
||
B subunit
|
Gal-Gb3
|
Oligoglycosylceramides
|
Rat small intestine
|
Gal(a1-3)Gal(a1-4)Gal(b1-4)Glc(b1-1)Cer
|
Binding
|
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01